Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 418679, 9 pages
http://dx.doi.org/10.1155/2012/418679
Research Article

Plectranthus amboinicus and Centella asiatica Cream for the Treatment of Diabetic Foot Ulcers

1Department of Surgery, National Taiwan University Hospital, Taipei 100, Taiwan
2Department of Surgery, National Taiwan University College of Medicine, No. 1, Section 1, Jen-Ai Road, Taipei 10051, Taiwan
3Oneness Biotech Co., Ltd., 7F-1, No. 3-1, Yuan Qu Street, Nangang District, Taipei 115, Taiwan

Received 17 February 2012; Accepted 5 April 2012

Academic Editor: Esra Küpeli Akkol

Copyright © 2012 Yuan-Sung Kuo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. G. Frykberg, “Diabetic foot ulcers: pathogenesis and management,” American Family Physician, vol. 66, no. 9, pp. 1655–1662, 2002. View at Google Scholar · View at Scopus
  2. M. S. Bader, “Diabetic foot infection,” American Family Physician, vol. 78, no. 1, pp. 71–79, 2008. View at Google Scholar · View at Scopus
  3. G. E. Reiber, D. G. Smith, L. Vileikyte et al., “Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings,” Diabetes Care, vol. 22, no. 1, pp. 157–162, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. R. G. Frykberg, B. Wittmayer, and T. Zgonis, “Surgical management of diabetic foot infections and osteomyelitis,” Clinics in Podiatric Medicine and Surgery, vol. 24, no. 3, pp. 469–482, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. B. A. Lipsky, A. R. Berendt, H. G. Deery et al., “Diagnosis and treatment of diabetic foot infections,” Clinical Infectious Diseases, vol. 39, no. 7, pp. 885–910, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. B. A. Lipsky, D. G. Armstrong, D. M. Citron, A. D. Tice, D. E. Morgenstern, and M. A. Abramson, “Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial,” The Lancet, vol. 366, no. 9498, pp. 1695–1703, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. B. A. Lipsky, P. Giordano, S. Choudhri, and J. Song, “Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/ amoxicillin-clavulanate,” Journal of Antimicrobial Chemotherapy, vol. 60, no. 2, pp. 370–376, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. B. S. Nagoba, R. C. Gandhi, B. J. Wadher, A. Rao, A. R. Hartalkar, and S. P. Selkar, “A simple and effective approach for the treatment of diabetic foot ulcers with different Wagner grades,” International Wound Journal, vol. 7, no. 3, pp. 153–158, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. L. C. Chen, B. R. Wang, Y. C. Chou, and J. H. Tien, “Drug utilization pattern of Chinese herbal medicines in a general hospital in Taiwan,” Pharmacoepidemiology and Drug Safety, vol. 14, no. 9, pp. 651–657, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. C. W. Lukhoba, M. S. J. Simmonds, and A. J. Paton, “Plectranthus: a review of ethnobotanical uses,” Journal of Ethnopharmacology, vol. 103, no. 1, pp. 1–24, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. A. P. A. D. Gurgel, J. G. da Silva, A. R. S. Grangeiro et al., “in vivo study of the anti-inflammatory and antitumor activities of leaves from Plectranthus amboinicus (Lour.) Spreng (Lamiaceae),” Journal of Ethnopharmacology, vol. 125, no. 2, pp. 361–363, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. J. Chiu, T. H. Huang, and C. S. Chiu, “Analgesic and antiinflammatory activities of the aqueous extract from Plectranthus amboinicus (Lour.) Spreng. Both in vitro and in vivo,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 508137, 11 pages, 2012. View at Publisher · View at Google Scholar
  13. A. Shukla, A. M. Rasik, G. K. Jain, R. Shankar, D. K. Kulshrestha, and B. N. Dhawan, “in vitro and in vivo wound healing activity of asiaticoside isolated from Centella asiatica,” Journal of Ethnopharmacology, vol. 65, no. 1, pp. 1–11, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Brinkhaus, M. Lindner, D. Schuppan, and E. G. Hahn, “Chemical, pharmacological and clinical profile of the East Asian medical plant Centella asiatica,” Phytomedicine, vol. 7, no. 5, pp. 427–448, 2000. View at Google Scholar · View at Scopus
  15. A. Piaggesi, F. Baccetti, L. Rizzo, M. Romanelli, R. Navalesi, and L. Benzi, “Sodium carboxyl-methyl-cellulose dressings in the management of deep ulcerations of diabetic foot,” Diabetic Medicine, vol. 18, no. 4, pp. 320–324, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. W. J. Jeffcoate, P. E. Price, C. J. Phillips et al., “Randomised controlled trial of the use of three dressing preparations in the management of chronic ulceration of the foot in diabetes,” Health Technology Assessment, vol. 13, no. 54, pp. 1–86, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Brown-Etris, C. Milne, H. Orsted et al., “A prospective, randomized, multisite clinical evaluation of a transparent absorbent acrylic dressing and a hydrocolloid dressing in the management of Stage II and shallow Stage III pressure ulcers,” Advances in Skin & Wound Care, vol. 21, no. 4, pp. 169–174, 2008. View at Google Scholar · View at Scopus
  18. E. Ernst, “Cardiovascular adverse effects of herbal medicines: a systematic review of the recent litarature,” Canadian Journal of Cardiology, vol. 19, no. 7, pp. 818–827, 2003. View at Google Scholar · View at Scopus
  19. E. Ernst, “Herbal medicines: balancing benefits and risks,” Novartis Foundation Symposium, vol. 282, pp. 154–167, 2007. View at Google Scholar · View at Scopus
  20. L. A. Lavery, D. G. Armstrong, and L. B. Harkless, “Classification of diabetic foot wounds,” Journal of Foot and Ankle Surgery, vol. 35, no. 6, pp. 528–531, 1996. View at Google Scholar · View at Scopus
  21. T. A. Mustoe, N. R. Cutler, R. M. Allman et al., “A phase II study to evaluate recombinant platelet-derived growth factor-BB in the treatment of stage 3 and 4 pressure ulcers,” Archives of Surgery, vol. 129, no. 2, pp. 213–219, 1994. View at Google Scholar · View at Scopus
  22. T. J. Wieman, J. M. Smiell, and Y. Su, “Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers: a phase III randomized placebo-controlled double-blind study,” Diabetes Care, vol. 21, no. 5, pp. 822–827, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Shukrimi, A. R. Sulaiman, A. Y. Halim, and A. Azril, “A comparative study between honey and povidone iodine as dressing solution for Wagner type II diabetic foot ulcers,” Medical Journal of Malaysia, vol. 63, no. 1, pp. 44–46, 2008. View at Google Scholar · View at Scopus